Table 1.
Characteristics of Study Population
| Characteristic | Patients (n = 10,177) | |
|---|---|---|
| n | % | |
| Age at Cancer Diagnosis, years | ||
| <55 | 589 | 5.8 |
| 55–64 | 2,688 | 26.4 |
| 65–74 | 4,277 | 42.0 |
| 75+ | 2,623 | 25.8 |
| Sex | ||
| Female | 3,980 | 39.1 |
| Male | 6,197 | 60.9 |
| Race/Ethnicity | ||
| Asian, non-Hispanic | 1,074 | 10.6 |
| African American, non-Hispanic | 937 | 9.2 |
| Hispanic | 1,054 | 10.4 |
| White, non-Hispanic | 6,497 | 63.8 |
| Native American/Alaskan Native | 33 | 0.3 |
| Multi-race | 577 | 5.7 |
| Unknown | 5 | 0.1 |
| Charlson Comorbidity Index Score | ||
| 0 | 4,105 | 40.3 |
| 1 | 2,765 | 27.2 |
| 2 | 1,683 | 16.5 |
| 3+ | 1,624 | 16.0 |
| Cancer Site | ||
| Breast | 3,153 | 31.0 |
| Colorectal | 1,762 | 17.3 |
| Prostate | 5,262 | 51.7 |
| Stage at Diagnosis | ||
| Localized | 8,372 | 82.3 |
| Regional | 1,805 | 17.7 |
| Year of Cancer Diagnosis | ||
| 2000–2004 | 1,856 | 18.2 |
| 2005–2008 | 4,010 | 39.4 |
| 2009–2012 | 4,311 | 42.4 |
Notes: Percentages may not equal 100 due to rounding. Abbreviation: n=number of participants